These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38837431)

  • 41. Analysis and reporting of stepped wedge randomised controlled trials: synthesis and critical appraisal of published studies, 2010 to 2014.
    Davey C; Hargreaves J; Thompson JA; Copas AJ; Beard E; Lewis JJ; Fielding KL
    Trials; 2015 Aug; 16():358. PubMed ID: 26278667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a covariate-constrained randomization procedure in stepped wedge cluster randomized trials.
    Chaussee EL; Dickinson LM; Fairclough DL
    Contemp Clin Trials; 2021 Jun; 105():106409. PubMed ID: 33894362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reconsidering stepped wedge cluster randomized trial designs with implementation periods: Fewer sequences or the parallel-group design with baseline and implementation periods are potentially more efficient.
    Westgate PM; Nigam SR; Shoben AB
    Clin Trials; 2024 Apr; ():17407745241244790. PubMed ID: 38650332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leveraging contact network structure in the design of cluster randomized trials.
    Harling G; Wang R; Onnela JP; De Gruttola V
    Clin Trials; 2017 Feb; 14(1):37-47. PubMed ID: 27798376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GEEMAEE: A SAS macro for the analysis of correlated outcomes based on GEE and finite-sample adjustments with application to cluster randomized trials.
    Zhang Y; Preisser JS; Li F; Turner EL; Toles M; Rathouz PJ
    Comput Methods Programs Biomed; 2023 Mar; 230():107362. PubMed ID: 36709555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substantial risks associated with few clusters in cluster randomized and stepped wedge designs.
    Taljaard M; Teerenstra S; Ivers NM; Fergusson DA
    Clin Trials; 2016 Aug; 13(4):459-63. PubMed ID: 26940696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel methods for the analysis of stepped wedge cluster randomized trials.
    Kennedy-Shaffer L; de Gruttola V; Lipsitch M
    Stat Med; 2020 Mar; 39(7):815-844. PubMed ID: 31876979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling clustering and treatment effect heterogeneity in parallel and stepped-wedge cluster randomized trials.
    Hemming K; Taljaard M; Forbes A
    Stat Med; 2018 Mar; 37(6):883-898. PubMed ID: 29315688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The batched stepped wedge design: A design robust to delays in cluster recruitment.
    Kasza J; Bowden R; Hooper R; Forbes AB
    Stat Med; 2022 Aug; 41(18):3627-3641. PubMed ID: 35596691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mixed-effects models for the design and analysis of stepped wedge cluster randomized trials: An overview.
    Li F; Hughes JP; Hemming K; Taljaard M; Melnick ER; Heagerty PJ
    Stat Methods Med Res; 2021 Feb; 30(2):612-639. PubMed ID: 32631142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stepped wedge designs could reduce the required sample size in cluster randomized trials.
    Woertman W; de Hoop E; Moerbeek M; Zuidema SU; Gerritsen DL; Teerenstra S
    J Clin Epidemiol; 2013 Jul; 66(7):752-8. PubMed ID: 23523551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statistical efficiency and optimal design for stepped cluster studies under linear mixed effects models.
    Girling AJ; Hemming K
    Stat Med; 2016 Jun; 35(13):2149-66. PubMed ID: 26748662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Key concepts in clinical epidemiology: Stepped wedge trials.
    Hooper R
    J Clin Epidemiol; 2021 Sep; 137():159-162. PubMed ID: 33892089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adherence to key recommendations for design and analysis of stepped-wedge cluster randomized trials: A review of trials published 2016-2022.
    Nevins P; Ryan M; Davis-Plourde K; Ouyang Y; Pereira Macedo JA; Meng C; Tong G; Wang X; Ortiz-Reyes L; Caille A; Li F; Taljaard M
    Clin Trials; 2024 Apr; 21(2):199-210. PubMed ID: 37990575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Information content of stepped-wedge designs when treatment effect heterogeneity and/or implementation periods are present.
    Kasza J; Taljaard M; Forbes AB
    Stat Med; 2019 Oct; 38(23):4686-4701. PubMed ID: 31321806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of cluster randomised stepped wedge trials with repeated cross-sectional samples.
    Hemming K; Taljaard M; Forbes A
    Trials; 2017 Mar; 18(1):101. PubMed ID: 28259174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inclusion of unexposed clusters improves the precision of fixed effects analysis of stepped-wedge cluster randomized trials.
    Lee KM; Ma X; Yang GM; Cheung YB
    Stat Med; 2022 Jul; 41(15):2923-2938. PubMed ID: 35352382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systematic review showed that stepped-wedge cluster randomized trials often did not reach their planned sample size.
    Eichner FA; Groenwold RHH; Grobbee DE; Oude Rengerink K
    J Clin Epidemiol; 2019 Mar; 107():89-100. PubMed ID: 30458261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing exposure-time treatment effect heterogeneity in stepped-wedge cluster randomized trials.
    Maleyeff L; Li F; Haneuse S; Wang R
    Biometrics; 2023 Sep; 79(3):2551-2564. PubMed ID: 36416302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.